Prelude Therapeutics Inc (PRLD)

CIK 1678660 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Prelude Therapeutics Inc.

Recent SEC filings

FiledFormAccession number
Sep 10, 20268-K0001193125-26-387232
Aug 11, 20268-K0001193125-26-343469
Aug 11, 202610-Q0001193125-26-343475
Jul 8, 2026SCHEDULE 13G0001213900-26-076456
Jun 10, 202640001435618-26-000006
Jun 10, 202640001620368-26-000003
Jun 10, 202640001193125-26-265965
Jun 10, 20268-K0001193125-26-265835
Jun 10, 202640001236927-26-000003
Jun 10, 202640001617541-26-000005
Jun 10, 202640001572451-26-000003
May 12, 202610-Q0001193125-26-218173
May 12, 20268-K0001193125-26-218162
May 4, 202640001489966-26-000004
Apr 29, 2026DEF 14A0001193125-26-191532
Apr 29, 2026ARS0001193125-26-191603
Apr 29, 2026DEFA14A0001193125-26-191565
Apr 28, 2026SCHEDULE 13G0001346824-26-000121
Apr 28, 202630001231919-26-000420
Apr 28, 202640001231919-26-000422
Apr 23, 2026SCHEDULE 13D/A0000947871-26-000463
Apr 23, 202640000947871-26-000462
Apr 23, 202640000947871-26-000461
Apr 22, 2026SCHEDULE 13D/A0001104659-26-046848
Apr 22, 202640001193125-26-170468